However, a major shift occurred in November 2025 when the Trump administration negotiated MFN pricing deals with Novo Nordisk and Eli Lilly, reducing Medicare/Medicaid prices for Ozempic, Wegovy, Zepbound, and Mounjaro to approximately $245/month , with Medicare beneficiary co-pays of $50/month ( [17] ) ( [22] )
Stormont Vail Pharmacist Nick Schulte says risk for shingles rises as you get older, so health experts want to be sure you're protected when you need it most
GLP-1 hair loss GLP-1 being a hormone that governs our appetite, which these drugs mimic is a very real side effect
The subsequent reduction in membrane-bound TREM2 impairs macrophage efferocytosis, sustains chronic inflammation, and contributes to the progression from simple steatosis to MASH (67)
They are used to clean the skin before injection